The peripheral arterial system includes all noncardiac arteries: the thoracic and abdominal
aortas and their branches extending to visceral organs and both upper and lower extremities …

BACKGROUND Peripheral arterial disease (PAD) is undertreated by general practitioners
(GPs). However, the impact of the suboptimal clinical management is unknown. OBJECTIVE …

Objective The prognosis of patients with peripheral arterial disease (PAD) is characterized
by an exceptionally high risk for myocardial infarction, ischemic stroke, and death; however …

Best medical therapy for peripheral artery disease (PAD) includes statin and anti-platelet
agents, a combination shown to decrease rates of major cardiovascular events. Despite …

Background Lower extremity peripheral arterial disease (PAD) is a marker of widespread
atherosclerosis. Individuals with PAD, most of whom do not show typical PAD symptoms …

Peripheral arterial disease (PAD) is a common condition associated with an increased risk
of coronary heart disease, myocardial infarction and stroke. It follows that PAD merits …

The term peripheral arterial disease (PAD) is often used to describe atherosclerosis
involving the arteries supplying the lower extremities. Potentially modifiable factors that …

Peripheral arterial disease (PAD) is a manifestation of widespread atherosclerosis. Lipid
modification (especially with statins) is a component of the treatment of patients with PAD …

Abstract Purpose of Review There is a lack of consistency among the ACC/AHA and ESC
Guidelines on the treatment of patients with lower extremity PAD to a targeted LDL-c level. A …

Background Peripheral arterial disease (PAD) is a marker of advanced atherosclerosis with
an elevated risk of cardiovascular mortality and morbidity. Although intensive risk reduction …